AflacLL1901 (CHOA-AML)
Clinical trial NCT04326439 · TERMINATED
Trial details
- NCT number
- NCT04326439
- Sponsor
- Emory University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-24
- Primary completion
- 2022-03-15
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.